Table 5

Reclassification of entire data set based on E/e’ thresholds of <8, 8–14 and >14

Variable	Overall		<8		E/e’ 8–14		15+		p Value
Variable	(N=1011)		(N=256)		(N=537)		(N=185)		p Value
Age	61.16	±16.43	49.73	±16.49	62.51	±14.30	72.65	±11.83	<0.001
Sex, n (%)									0.07
Male	332	33	81	32	188	35	48	26
Female	679	67	175	68	349	65	137	74
HTN, n (%)	471	47	72	28	263	49	119	65	<0.001
DM, n (%)	137	14	22	9	67	13	46	25	<0.001
CAD, n (%)	115	11	16	6	61	11	34	18	<0.001
Smoke, n (%)	71	7	20	8	38	7	10	5	0.61
D grade, n (%)									<0.001
0	508	59	194	78	257	56	36	31
1	246	29	50	20	176	38	12	10
1a	154	15	32	13	88	16	30	16
2	92	11	3	1	26	6	61	53
3	9	1	1	0	1	0	7	4
Vit D Rx			68/249 (27%)		161/523 (30.8%)		75/178 (42.1%)		0.0036
25 Vit D, ng/mL	31.37	±15.59	31.1	±14.89	31.45	±16.64	32.15	±13.88	0.78
Ca²⁺	9.5	±2.76	9.37	±0.66	9.45	±0.72	9.87	±6.29	0.15
Cr	0.94	±0.65	0.84	±0.24	0.94	±0.56	1.05	±0.90	0.001
EF	64.22	±5.93	63.88	±5.38	64.26	±5.71	64.74	±6.98	0.32
IVS	10.84	±4.72	9.73	±1.68	10.78	±1.85	11.65	±2.50	<0.001
Mass	89.27	±25.34	79.87	±19.51	89.07	±21.89	100.81	±32.80	<0.001
LVEDD	44.91	±5.30	45.15	±4.92	44.82	±5.20	44.67	±5.92	0.61
LA Vol	30.35	±10.62	25.83	±7.25	30.12	±10.01	36.23	±10.49	<0.001
E/A	1.13	±0.48	1.33	±0.56	1.07	±0.41	1.07	±0.46	<0.001
DT	213.77	±53.54	205	±47.60	214.14	±49.85	226.84	±68.07	<0.001
e’	0.08	±0.05	0.11	±0.03	0.08	±0.05	0.06	±0.06	<0.001
E/e’	11.34	±5.55	6.51	±0.98	10.6	±1.78	20.19	±6.36	<0.001
RVSP	31.89	±9.70	28.32	±8.60	31.63	±8.36	36.5	±12.00	<0.001

A, late mitral diastolic flow velocity; BMI, body mass index; CAD, coronary artery disease; DM, diabetes mellitus; DT, deceleration time of mitral E wave; E, early mitral diastolic flow velocity; e’, early diastolic mitral annular velocity, EF, ejection fraction; HTN, hypertension, IVS, interventricular septum; n, sample size, LA, left atrium; LAVI, left atrial volume index; LV, left ventricular; LVEDD, left ventricular end diastolic dimension; RVSP, right ventricular systolic pressure.